Evaluation of clomiphene citrate and human chorionic gonadotropin treatment

A prospective, randomized, crossover study during intrauterine insemination cycles

A. Arici, W. Byrd, K. Bradshaw, W. H. Kutteh, P. Marshburn, B. R. Carr

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Objective: To test the hypothesis that in couples undergoing IUI, actively managed cycles using clomiphene citrate (CC) stimulation, ultrasound monitoring, and hCG timing will result in increased pregnancy rate (PR) per cycle compared with unstimulated urinary LH-timed cycles. Patients: Fifty- six couples with unexplained infertility (n = 26) or male factor infertility (n = 30) participated in the study. Setting: Tertiary academic medical center. Design: Prospective, randomized, crossover. Couples were randomized initially to one of the two study groups (treatment A: LH-timed IUI; treatment B: CC-stimulated, hCG-timed IUI). If no pregnancy occurred, each couple alternated between the two regimens during subsequent cycles, up to a total of four cycles. Results: Twenty-nine couples completed the study and the analysis of 95 cycles revealed that among the male factor infertility group, one pregnancy occurred during the 26 cycles of each treatment group (PR per cycle of 3.9% for both treatment groups). In contrast, among the unexplained infertility group, there was a marked difference in the effect of treatments. During treatment A only one pregnancy occurred in 20 cycles (PR of 5% per cycle) whereas during treatment B, six pregnancies occurred in 23 cycles (PR of 26.1% per cycle). Conclusions: If IUI is chosen as the treatment modality in unexplained infertility, the addition of active ovulation management that includes CC stimulation, ultrasound monitoring of folliculo-genesis, and hCG timing of ovulation increases the PR per cycle. In couples with male infertility, PR per cycle is low and is apparently not affected by the addition of active ovulation management.

Original languageEnglish (US)
Pages (from-to)314-318
Number of pages5
JournalFertility and Sterility
Volume61
Issue number2
StatePublished - 1994

Fingerprint

Clomiphene
Insemination
Chorionic Gonadotropin
Cross-Over Studies
Pregnancy Rate
Male Infertility
Ovulation
Infertility
Pregnancy
Therapeutics

Keywords

  • Clomiphene citrate
  • intrauterine insemination
  • male factor infertility
  • unexplained infertility

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Evaluation of clomiphene citrate and human chorionic gonadotropin treatment : A prospective, randomized, crossover study during intrauterine insemination cycles. / Arici, A.; Byrd, W.; Bradshaw, K.; Kutteh, W. H.; Marshburn, P.; Carr, B. R.

In: Fertility and Sterility, Vol. 61, No. 2, 1994, p. 314-318.

Research output: Contribution to journalArticle

@article{8a0794864f6d4f959bf16dd85bc92726,
title = "Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: A prospective, randomized, crossover study during intrauterine insemination cycles",
abstract = "Objective: To test the hypothesis that in couples undergoing IUI, actively managed cycles using clomiphene citrate (CC) stimulation, ultrasound monitoring, and hCG timing will result in increased pregnancy rate (PR) per cycle compared with unstimulated urinary LH-timed cycles. Patients: Fifty- six couples with unexplained infertility (n = 26) or male factor infertility (n = 30) participated in the study. Setting: Tertiary academic medical center. Design: Prospective, randomized, crossover. Couples were randomized initially to one of the two study groups (treatment A: LH-timed IUI; treatment B: CC-stimulated, hCG-timed IUI). If no pregnancy occurred, each couple alternated between the two regimens during subsequent cycles, up to a total of four cycles. Results: Twenty-nine couples completed the study and the analysis of 95 cycles revealed that among the male factor infertility group, one pregnancy occurred during the 26 cycles of each treatment group (PR per cycle of 3.9{\%} for both treatment groups). In contrast, among the unexplained infertility group, there was a marked difference in the effect of treatments. During treatment A only one pregnancy occurred in 20 cycles (PR of 5{\%} per cycle) whereas during treatment B, six pregnancies occurred in 23 cycles (PR of 26.1{\%} per cycle). Conclusions: If IUI is chosen as the treatment modality in unexplained infertility, the addition of active ovulation management that includes CC stimulation, ultrasound monitoring of folliculo-genesis, and hCG timing of ovulation increases the PR per cycle. In couples with male infertility, PR per cycle is low and is apparently not affected by the addition of active ovulation management.",
keywords = "Clomiphene citrate, intrauterine insemination, male factor infertility, unexplained infertility",
author = "A. Arici and W. Byrd and K. Bradshaw and Kutteh, {W. H.} and P. Marshburn and Carr, {B. R.}",
year = "1994",
language = "English (US)",
volume = "61",
pages = "314--318",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Evaluation of clomiphene citrate and human chorionic gonadotropin treatment

T2 - A prospective, randomized, crossover study during intrauterine insemination cycles

AU - Arici, A.

AU - Byrd, W.

AU - Bradshaw, K.

AU - Kutteh, W. H.

AU - Marshburn, P.

AU - Carr, B. R.

PY - 1994

Y1 - 1994

N2 - Objective: To test the hypothesis that in couples undergoing IUI, actively managed cycles using clomiphene citrate (CC) stimulation, ultrasound monitoring, and hCG timing will result in increased pregnancy rate (PR) per cycle compared with unstimulated urinary LH-timed cycles. Patients: Fifty- six couples with unexplained infertility (n = 26) or male factor infertility (n = 30) participated in the study. Setting: Tertiary academic medical center. Design: Prospective, randomized, crossover. Couples were randomized initially to one of the two study groups (treatment A: LH-timed IUI; treatment B: CC-stimulated, hCG-timed IUI). If no pregnancy occurred, each couple alternated between the two regimens during subsequent cycles, up to a total of four cycles. Results: Twenty-nine couples completed the study and the analysis of 95 cycles revealed that among the male factor infertility group, one pregnancy occurred during the 26 cycles of each treatment group (PR per cycle of 3.9% for both treatment groups). In contrast, among the unexplained infertility group, there was a marked difference in the effect of treatments. During treatment A only one pregnancy occurred in 20 cycles (PR of 5% per cycle) whereas during treatment B, six pregnancies occurred in 23 cycles (PR of 26.1% per cycle). Conclusions: If IUI is chosen as the treatment modality in unexplained infertility, the addition of active ovulation management that includes CC stimulation, ultrasound monitoring of folliculo-genesis, and hCG timing of ovulation increases the PR per cycle. In couples with male infertility, PR per cycle is low and is apparently not affected by the addition of active ovulation management.

AB - Objective: To test the hypothesis that in couples undergoing IUI, actively managed cycles using clomiphene citrate (CC) stimulation, ultrasound monitoring, and hCG timing will result in increased pregnancy rate (PR) per cycle compared with unstimulated urinary LH-timed cycles. Patients: Fifty- six couples with unexplained infertility (n = 26) or male factor infertility (n = 30) participated in the study. Setting: Tertiary academic medical center. Design: Prospective, randomized, crossover. Couples were randomized initially to one of the two study groups (treatment A: LH-timed IUI; treatment B: CC-stimulated, hCG-timed IUI). If no pregnancy occurred, each couple alternated between the two regimens during subsequent cycles, up to a total of four cycles. Results: Twenty-nine couples completed the study and the analysis of 95 cycles revealed that among the male factor infertility group, one pregnancy occurred during the 26 cycles of each treatment group (PR per cycle of 3.9% for both treatment groups). In contrast, among the unexplained infertility group, there was a marked difference in the effect of treatments. During treatment A only one pregnancy occurred in 20 cycles (PR of 5% per cycle) whereas during treatment B, six pregnancies occurred in 23 cycles (PR of 26.1% per cycle). Conclusions: If IUI is chosen as the treatment modality in unexplained infertility, the addition of active ovulation management that includes CC stimulation, ultrasound monitoring of folliculo-genesis, and hCG timing of ovulation increases the PR per cycle. In couples with male infertility, PR per cycle is low and is apparently not affected by the addition of active ovulation management.

KW - Clomiphene citrate

KW - intrauterine insemination

KW - male factor infertility

KW - unexplained infertility

UR - http://www.scopus.com/inward/record.url?scp=0028055295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028055295&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 314

EP - 318

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -